Issue link: https://www.e-digitaleditions.com/i/1491587
Inhalation February 2023 33 Development of drug/device combination products e Recipharm team has extensive experience across the lifecycle of pharmaceutical development and manufacturing. We exceed customer expectations and provide reliable guidance for customer programs. By providing expertise in the development of combined drug/device products together with commercial man- ufacturing, Recipharm can minimize hurdles and reduce time to market. We have implemented tech- nology platforms to provide drug formulation devel- opment expertise, comprehensive analytical support and manufacturing capabilities for a range of inhala- tion products. Recipharm UK: +44 1553 691000 www.recipharm.com www.inhalationmag.com Redesigned to increase its educational content, the Inhalation 1-2-3 e-newsletter provides a supplier's perspective on industry issues, highlights technical articles from the magazine and previews industry conferences. Please watch for it in your inbox every other month. Sign up now by emailing your name, company name and email address to subscriptions@inhalationmag.com.